Methods and products related to glutaminase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10786471
APP PUB NO 20180221321A1
SERIAL NO

15890220

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to methods and related compositions for enhancing cancer therapy and in particular glutaminase inhibitor therapy. The methods involve methods for identifying patients susceptible to glutaminase inhibitor therapy as well as sensitizing patients to glutaminase inhibitor therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MASSACHUSETTS INSTITUTE OF TECHNOLOGY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Danai, Laura Brighton, US 1 0
Gui, Dan Yi Cambridge, US 2 11
Heiden, Matthew Vander Cambridge, US 1 0
Muir, Alexander Cambridge, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 29, 2024
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 29, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 29, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00